Hyperactive disorder drug 'raises risk of suicidal thoughts in children'

[emad]

Hyperactive disorder drug 'raises risk of suicidal thoughts in children'
By Jeremy Laurance, Health Editor
Published: 30 September 2005


A drug taken by 15,000 children in the UK has been found to increase the risk of suicidal thoughts, the Government's medicines safety watchdog says.

Strattera, which is manufactured by Lilly and is used to treat attention deficit and hyperactive disorder (ADHD), was licensed in the UK in July 2004.

Yesterday's warning was issued by the Medicines and Healthcare Regulatory Agency (MHRA), which said it would re-examine the risks and benefits of the drug. It follows the finding of an increased risk of suicide in children and young people taking antidepressants called Selective Serotonin Re-uptake Inhibitors (SSRIs). All SSRIs except Prozac were banned in children by the MHRA in December 2003.

June Raine, the director of medicines post-licensing at the MHRA, said: "We are advising healthcare professionals that patients should be carefully monitored for signs of depression, suicidal thoughts or suicidal behaviour and referred for alternative treatment if necessary.

http://news.independent.co.uk/uk/health_medical/article316091.ece